These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

527 related items for PubMed ID: 24125734

  • 21. 1α,25-Dihydroxyvitamin D Inhibits the Metastatic Capability of MCF10CA1a and MDA-MB-231 Cells in an In Vitro Model of Breast to Bone Metastasis.
    Wilmanski T, Barnard A, Parikh MR, Kirshner J, Buhman K, Burgess J, Teegarden D.
    Nutr Cancer; 2016 Oct; 68(7):1202-9. PubMed ID: 27552186
    [Abstract] [Full Text] [Related]

  • 22. 1α,25(OH)₂D₃ Suppresses the Migration of Ovarian Cancer SKOV-3 Cells through the Inhibition of Epithelial-Mesenchymal Transition.
    Hou YF, Gao SH, Wang P, Zhang HM, Liu LZ, Ye MX, Zhou GM, Zhang ZL, Li BY.
    Int J Mol Sci; 2016 Aug 19; 17(8):. PubMed ID: 27548154
    [Abstract] [Full Text] [Related]

  • 23. Antiproliferative signalling by 1,25(OH)2D3 in prostate and breast cancer is suppressed by a mechanism involving histone deacetylation.
    Banwell CM, Singh R, Stewart PM, Uskokovic MR, Campbell MJ.
    Recent Results Cancer Res; 2003 Aug 19; 164():83-98. PubMed ID: 12899515
    [Abstract] [Full Text] [Related]

  • 24. Differential effects of 1,25-dihydroxyvitamin D3 and tetradecanoylphorbol acetate on cell cycle and apoptosis of MCF-7 cells and a vitamin D3-resistant variant.
    Narvaez CJ, Welsh J.
    Endocrinology; 1997 Nov 19; 138(11):4690-8. PubMed ID: 9348195
    [Abstract] [Full Text] [Related]

  • 25. Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5.
    Mehta RG, Moriarty RM, Mehta RR, Penmasta R, Lazzaro G, Constantinou A, Guo L.
    J Natl Cancer Inst; 1997 Feb 05; 89(3):212-8. PubMed ID: 9017001
    [Abstract] [Full Text] [Related]

  • 26. Vitamin D and systemic cancer: is this relevant to malignant melanoma?
    Osborne JE, Hutchinson PE.
    Br J Dermatol; 2002 Aug 05; 147(2):197-213. PubMed ID: 12174089
    [Abstract] [Full Text] [Related]

  • 27. PDLIM2 expression is driven by vitamin D and is involved in the pro-adhesion, and anti-migration and -invasion activity of vitamin D.
    Vanoirbeek E, Eelen G, Verlinden L, Carmeliet G, Mathieu C, Bouillon R, O'Connor R, Xiao G, Verstuyf A.
    Oncogene; 2014 Apr 10; 33(15):1904-11. PubMed ID: 23584482
    [Abstract] [Full Text] [Related]

  • 28. Snail2 cooperates with Snail1 in the repression of vitamin D receptor in colon cancer.
    Larriba MJ, Martín-Villar E, García JM, Pereira F, Peña C, de Herreros AG, Bonilla F, Muñoz A.
    Carcinogenesis; 2009 Aug 10; 30(8):1459-68. PubMed ID: 19502595
    [Abstract] [Full Text] [Related]

  • 29. 1,25(OH)2D3 attenuates TGF-β1/β2-induced increased migration and invasion via inhibiting epithelial-mesenchymal transition in colon cancer cells.
    Chen S, Zhu J, Zuo S, Ma J, Zhang J, Chen G, Wang X, Pan Y, Liu Y, Wang P.
    Biochem Biophys Res Commun; 2009 Aug 10; 468(1-2):130-5. PubMed ID: 26523511
    [Abstract] [Full Text] [Related]

  • 30. Evaluation of vitamin D analogs as therapeutic agents for prostate cancer.
    Chen TC, Holick MF, Lokeshwar BL, Burnstein KL, Schwartz GG.
    Recent Results Cancer Res; 2003 Aug 10; 164():273-88. PubMed ID: 12899529
    [Abstract] [Full Text] [Related]

  • 31. Human cytochrome P450-dependent differential metabolism among three 2α-substituted-1α,25-dihydroxyvitamin D(3) analogs.
    Yasuda K, Ikushiro S, Kamakura M, Takano M, Saito N, Kittaka A, Chen TC, Ohta M, Sakaki T.
    J Steroid Biochem Mol Biol; 2013 Jan 10; 133():84-92. PubMed ID: 22982757
    [Abstract] [Full Text] [Related]

  • 32. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
    Skowronski RJ, Peehl DM, Feldman D.
    Endocrinology; 1995 Jan 10; 136(1):20-6. PubMed ID: 7530193
    [Abstract] [Full Text] [Related]

  • 33. CRH suppressed TGFβ1-induced Epithelial-Mesenchymal Transition via induction of E-cadherin in breast cancer cells.
    Jin L, Chen J, Li L, Li C, Chen C, Li S.
    Cell Signal; 2014 Apr 10; 26(4):757-65. PubMed ID: 24412750
    [Abstract] [Full Text] [Related]

  • 34. Osteopontin up-regulates critical epithelial-mesenchymal transition transcription factors to induce an aggressive breast cancer phenotype.
    Li NY, Weber CE, Mi Z, Wai PY, Cuevas BD, Kuo PC.
    J Am Coll Surg; 2013 Jul 10; 217(1):17-26; discussion 26. PubMed ID: 23619316
    [Abstract] [Full Text] [Related]

  • 35. 24R,25-Dihydroxyvitamin D3 regulates breast cancer cells in vitro and in vivo.
    Verma A, Cohen DJ, Schwartz N, Muktipaty C, Koblinski JE, Boyan BD, Schwartz Z.
    Biochim Biophys Acta Gen Subj; 2019 Oct 10; 1863(10):1498-1512. PubMed ID: 31125679
    [Abstract] [Full Text] [Related]

  • 36. Comparative effects of 1,25(OH)2D3 and EB1089 on cell cycle kinetics and apoptosis in MCF-7 breast cancer cells.
    Simboli-Campbell M, Narvaez CJ, van Weelden K, Tenniswood M, Welsh J.
    Breast Cancer Res Treat; 1997 Jan 10; 42(1):31-41. PubMed ID: 9116316
    [Abstract] [Full Text] [Related]

  • 37. Selective inhibition of cyclooxygenase-2 (COX-2) by 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3, a less calcemic vitamin D analog.
    Aparna R, Subhashini J, Roy KR, Reddy GS, Robinson M, Uskokovic MR, Venkateswara Reddy G, Reddanna P.
    J Cell Biochem; 2008 Aug 01; 104(5):1832-42. PubMed ID: 18348265
    [Abstract] [Full Text] [Related]

  • 38. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
    Kubota T, Koshizuka K, Koike M, Uskokovic M, Miyoshi I, Koeffler HP.
    Cancer Res; 1998 Aug 01; 58(15):3370-5. PubMed ID: 9699668
    [Abstract] [Full Text] [Related]

  • 39. Efficacy and mechanism of action of 1alpha-hydroxy-24-ethyl-cholecalciferol (1alpha[OH]D5) in breast cancer prevention and therapy.
    Hussain EA, Mehta RR, Ray R, Das Gupta TK, Mehta RG.
    Recent Results Cancer Res; 2003 Aug 01; 164():393-411. PubMed ID: 12899538
    [Abstract] [Full Text] [Related]

  • 40. Vitamin D3 analogs and their 24-oxo metabolites equally inhibit clonal proliferation of a variety of cancer cells but have differing molecular effects.
    Campbell MJ, Reddy GS, Koeffler HP.
    J Cell Biochem; 1997 Sep 01; 66(3):413-25. PubMed ID: 9257197
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.